NEW YORK (

TheStreet

) -- The ex-dividend date for

Pharmaceutical Product Development

(Nasdaq:

PPDI

) is tomorrow, March 11, 2011. Owners of shares as of market close today will be eligible for a dividend of 15 cents per share. At a price of $28.29 as of 10:21 a.m. ET, the dividend yield is 2.1%.

The average volume for Pharmaceutical Product Development has been 758,600 shares per day over the past 30 days. Pharmaceutical Product Development has a market cap of $3.3 billion and is part of the

health care

sector and

health services

industry. Shares are up 6.8% year to date as of the close of trading on Wednesday.

Pharmaceutical Product Development, Inc., a contract research organization, provides drug discovery and development services. The company operates in two segments, Development and Discovery Sciences. The company has a P/E ratio of 27.8, below the average health services industry P/E ratio of 28.1 and above the S&P 500 P/E ratio of 17.5.

TheStreet Ratings rates Pharmaceutical Product Development as hold. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels and expanding profit margins. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full

Pharmaceutical Product Development Ratings Report

.

See our

dividend calendar

or

top-yielding stocks list

.

null